Suchergebnisse - "Valeri, Nicola"

PubPharm (163)

91

Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases

enthalten in: Cancer cell international | 2018

von Fassan, M. | Vianello, L. | Sacchi, D. | +16

ErratumIn: Cancer Cell Int. 2019 Sep 24;19:244. - PMID 31572061

92

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

Erschienen: 2018

von Vlachogiannis, G. | Hedayat, S. | Vatsiou, A. | +40

93

First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction : final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study

enthalten in: Oncotarget | 2017

von Tomasello, G. | Valeri, N. | Ghidini, M. | +17

94

Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial : Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Smyth, E. | Zhang, S. | Cunningham, D. | +12

95

Characterisation of the immune-related transcriptome in resected biliary tract cancers

enthalten in: European journal of cancer (Oxford, England : 1990) | 2017

von Ghidini, M. | Cascione, L. | Carotenuto, P. | +17

96

Mismatch Repair Deficiency, Microsatellite Instability, and Survival : An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial

enthalten in: JAMA oncology | 2017

von Smyth, E. | Wotherspoon, A. | Peckitt, C. | +13

ErratumIn: JAMA Oncol. 2022 Sep 1;8(9):1359. - PMID 35834228

97

A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER) : study protocol for a randomised controlled trial

enthalten in: Trials | 2017

von Battersby, N. | Dattani, M. | Rao, S. | +17

98

A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial

enthalten in: Trials | 2017

von Battersby, N. | Dattani, M. | Rao, S. | +17

99

A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial

enthalten in: Trials | 2017

von Battersby, N. | Dattani, M. | Rao, S. | +17

100

Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers

enthalten in: Gut | 2017

von Carotenuto, P. | Fassan, M. | Pandolfo, R. | +29

CommentIn: Gut. 2017 Jul;66(7):1177-1178. - PMID 27986786